Northeast Financial Consultants’s BioCryst Pharmaceuticals BCRX Stock Holding History

Northeast Financial Consultants’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$588K	Hold	65,633	–	–	0.02%	190
2025 Q1	$492K	Hold	65,633	–	–	0.02%	200
2024 Q4	$494K	Hold	65,633	–	–	0.02%	193
2024 Q3	$499K	Hold	65,633	–	–	0.02%	197
2024 Q2	$406K	Buy	65,633 +5,000	+8%	+$30.9K	0.02%	206
2024 Q1	$308K	Hold	60,633	–	–	0.02%	237
2023 Q4	$363K	Hold	60,633	–	–	0.02%	217
2023 Q3	$429K	Hold	60,633	–	–	0.03%	196
2023 Q2	$427K	Hold	60,633	–	–	0.03%	199
2023 Q1	$506K	Hold	60,633	–	–	0.03%	186
2022 Q4	$696K	Hold	60,633	–	–	0.05%	155
2022 Q3	$764K	Hold	60,633	–	–	0.06%	156
2022 Q2	$641K	Hold	60,633	–	–	0.04%	167
2022 Q1	$986K	Hold	60,633	–	–	0.06%	161
2021 Q4	$840K	Buy	60,633 +30,633	+102%	+$424K	0.05%	172
2021 Q3	$431K	Buy	30,000 +10,000	+50%	+$144K	0.03%	238
2021 Q2	$316K	Hold	20,000	–	–	0.02%	275
2021 Q1	$203K	Sell	20,000 -13,157	-40%	-$134K	0.02%	317
2020 Q4	$247K	Hold	33,157	–	–	0.02%	282
2020 Q3	$114K	Buy	33,157 +13,157	+66%	+$45.2K	0.01%	295
2020 Q2	$95K	Hold	20,000	–	–	0.01%	288
2020 Q1	$40K	Hold	20,000	–	–	﹤0.01%	264
2019 Q4	$69K	Hold	20,000	–	–	0.01%	301
2019 Q3	$57K	Hold	20,000	–	–	0.01%	318
2019 Q2	$76K	Hold	20,000	–	–	0.01%	322
2019 Q1	$163K	Hold	20,000	–	–	0.02%	308
2018 Q4	$161K	Hold	20,000	–	–	0.02%	149
2018 Q3	$152K	Hold	20,000	–	–	0.04%	148
2018 Q2	$114K	Hold	20,000	–	–	0.04%	144
2018 Q1	$95K	Hold	20,000	–	–	0.03%	145
2017 Q4	$98K	Hold	20,000	–	–	0.03%	152
2017 Q3	$105K	Hold	20,000	–	–	0.04%	149
2017 Q2	$111K	Hold	20,000	–	–	0.04%	141
2017 Q1	$168K	Hold	20,000	–	–	0.07%	145
2016 Q4	$127K	Hold	20,000	–	–	0.06%	139
2016 Q3	$88K	Hold	20,000	–	–	0.04%	152
2016 Q2	$57K	Hold	20,000	–	–	0.03%	147
2016 Q1	$57K	Hold	20,000	–	–	0.03%	133
2015 Q4	$206K	Hold	20,000	–	–	0.11%	123
2015 Q3	$228K	Hold	20,000	–	–	0.12%	119
2015 Q2	$299K	Hold	20,000	–	–	0.13%	116
2015 Q1	$181K	Buy	20,000 +10,000	+100%	+$90.5K	0.08%	137
2014 Q4	$121K	Hold	10,000	–	–	0.06%	129
2014 Q3	$98K	Buy	+10,000	New	+$98K	0.05%	132